Cargando…

Simvastatin for patients with acute respiratory distress syndrome: long-term outcomes and cost-effectiveness from a randomised controlled trial

BACKGROUND: Simvastatin therapy for patients with acute respiratory distress syndrome (ARDS) has been shown to be safe and associated with minimal adverse effects, but it does not improve clinical outcomes. The aim of this research was to report on mortality and cost-effectiveness of simvastatin in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Agus, A., Hulme, C., Verghis, R. M., McDowell, C., Jackson, C., O’Kane, C. M., Laffey, J. G., McAuley, D. F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5434552/ https://www.ncbi.nlm.nih.gov/pubmed/28511660 http://dx.doi.org/10.1186/s13054-017-1695-0

Ejemplares similares

Re-analysis of ventilator-free days (VFD) in acute respiratory distress syndrome (ARDS) studies
por: Verghis, Rejina Mariam, et al.
Publicado: (2023)

The relationship between plasma cystatin C, mortality and acute respiratory distress syndrome subphenotype in the HARP-2 trial
por: McKelvey, Michael C., et al.
Publicado: (2023)

Keratinocyte growth factor in acute lung injury to reduce pulmonary dysfunction – a randomised placebo-controlled trial (KARE): study protocol
por: Cross, Laurence JM, et al.
Publicado: (2013)

Repair of Acute Respiratory Distress Syndrome by Stromal Cell Administration in COVID-19 (REALIST-COVID-19): A structured summary of a study protocol for a randomised, controlled trial
por: Gorman, Ellen, et al.
Publicado: (2020)

Simvastatin decreases the level of heparin-binding protein in patients with acute lung injury
por: McAuley, Daniel F, et al.
Publicado: (2013)

Erratum to: Keratinocyte growth factor in acute lung injury to reduce pulmonary dysfunction – a randomised placebo-controlled trial (KARE): study protocol
por: Cross, Laurence J. M., et al.
Publicado: (2017)

Identifying associations between diabetes and acute respiratory distress syndrome in patients with acute hypoxemic respiratory failure: an analysis of the LUNG SAFE database
por: Boyle, Andrew J., et al.
Publicado: (2018)

Evaluating early administration of the hydroxymethylglutaryl-CoA reductase inhibitor simvastatin in the prevention and treatment of delirium in critically ill ventilated patients (MoDUS trial): study protocol for a randomized controlled trial
por: Casarin, Annalisa, et al.
Publicado: (2015)

Hydroxymethylglutaryl-CoA reductase inhibition with simvastatin in Acute lung injury to Reduce Pulmonary dysfunction (HARP-2) trial: study protocol for a randomized controlled trial
por: McAuley, Daniel F, et al.
Publicado: (2012)

Individual patient data analysis of tidal volumes used in three large randomized control trials involving patients with acute respiratory distress syndrome
por: Poole, J., et al.
Publicado: (2017)

Acute hypoxaemic respiratory failure after treatment with lower tidal volume ventilation facilitated by extracorporeal carbon dioxide removal: long-term outcomes from the REST randomised trial
por: Boyle, Andrew J, et al.
Publicado: (2023)

Repair of acute respiratory distress syndrome by stromal cell administration (REALIST) trial: A phase 1 trial
por: Gorman, Ellen, et al.
Publicado: (2021)

Heterogeneity of surrogate outcome measures used in critical care studies: A systematic review
por: Verghis, Rejina, et al.
Publicado: (2023)

Repair of acute respiratory distress syndrome by stromal cell administration (REALIST): a structured study protocol for an open-label dose-escalation phase 1 trial followed by a randomised, triple-blind, allocation concealed, placebo-controlled phase 2 trial
por: Gorman, Ellen, et al.
Publicado: (2022)

Baseline plasma IL-18 may predict simvastatin treatment response in patients with ARDS: a secondary analysis of the HARP-2 randomised clinical trial
por: Boyle, Andrew James, et al.
Publicado: (2022)

0995. Aspirin reduces neutrophilic pulmonary inflammation in a human model of acute respiratory distress syndrome induced by inhaled lipopolysaccharide
por: Hamid, U Imran, et al.
Publicado: (2014)

Acute respiratory distress syndrome
por: Sweeney, Rob Mac, et al.
Publicado: (2016)

Acute Respiratory Distress Syndrome
por: Adams, Claire E., et al.
Publicado: (2022)

Prevention of post-operative complications by using a HMG-CoA reductase inhibitor in patients undergoing one-lung ventilation for non-cardiac surgery: study protocol for a randomised controlled trial
por: Shyamsundar, Murali, et al.
Publicado: (2018)

Effect of prone position on pulmonary vascular permeability in acute respiratory distress syndrome
por: McAuley, D, et al.
Publicado: (2001)

Effectiveness of a programme of exercise on physical function in survivors of critical illness following discharge from the ICU: study protocol for a randomised controlled trial (REVIVE)
por: O'Neill, Brenda, et al.
Publicado: (2014)

Aspirin as a potential treatment in sepsis or acute respiratory distress syndrome
por: Toner, Philip, et al.
Publicado: (2015)

Aspirin therapy in patients with acute respiratory distress syndrome (ARDS) is associated with reduced intensive care unit mortality: a prospective analysis
por: Boyle, Andrew J, et al.
Publicado: (2015)

Spontaneous Breathing in Early Acute Respiratory Distress Syndrome: Insights From the Large Observational Study to UNderstand the Global Impact of Severe Acute Respiratory FailurE Study*
por: van Haren, Frank, et al.
Publicado: (2019)

Heterogeneity of treatment effect by baseline risk of mortality in critically ill patients: re-analysis of three recent sepsis and ARDS randomised controlled trials
por: Santhakumaran, Shalini, et al.
Publicado: (2019)

Acute Respiratory Distress Syndrome Subphenotypes beyond the Syndrome: A Step toward Treatable Traits?
por: Reddy, Kiran, et al.
Publicado: (2021)

The Effectiveness of Individual or Group Physiotherapy in the Management of Sub-Acromial Impingement: A Randomised Controlled Trial and Health Economic Analysis
por: Ryans, Ian, et al.
Publicado: (2020)

The Impact of Aging in Acute Respiratory Distress Syndrome: A Clinical and Mechanistic Overview
por: Brown, Ryan, et al.
Publicado: (2020)

Comparison of machine learning clustering algorithms for detecting heterogeneity of treatment effect in acute respiratory distress syndrome: A secondary analysis of three randomised controlled trials
por: Sinha, Pratik, et al.
Publicado: (2021)

Prevalence of phenotypes of acute respiratory distress syndrome in critically ill patients with COVID-19: a prospective observational study
por: Sinha, Pratik, et al.
Publicado: (2020)

COVID-19–related Acute Respiratory Distress Syndrome Subphenotypes and Differential Response to Corticosteroids: Time for More Precision?
por: Reddy, Kiran, et al.
Publicado: (2021)

Bench-to-bedside review: β(2)-Agonists and the acute respiratory distress syndrome
por: Perkins, Gavin D, et al.
Publicado: (2004)

Understanding the Role of Mesenchymal Stromal Cells in Treating COVID-19 Acute Respiratory Distress Syndrome
por: O’Kane, Cecilia M., et al.
Publicado: (2022)

Clinically relevant concentrations of beta agonists may stimulate alveolar fluid clearance in acute respiratory distress syndrome
por: Perkins, G, et al.
Publicado: (2004)

Hypercapnic acidosis induces mitochondrial dysfunction and impairs the ability of mesenchymal stem cells to promote distal lung epithelial repair
por: Fergie, Nicola, et al.
Publicado: (2019)

Sedation AND Weaning In Children (SANDWICH): protocol for a cluster randomised stepped wedge trial
por: Blackwood, Bronagh, et al.
Publicado: (2019)

Effect of intravenous β-2 agonist treatment on clinical outcomes in acute respiratory distress syndrome (BALTI-2): a multicentre, randomised controlled trial
por: Smith, Fang Gao, et al.
Publicado: (2012)

Extracorporeal carbon dioxide removal for patients with acute respiratory failure secondary to the acute respiratory distress syndrome: a systematic review
por: Fitzgerald, Marianne, et al.
Publicado: (2014)

Reply to Zhang and Hei: Mesenchymal Stem Cell–derived Exosomes: Are They Another Therapeutic Method for Extracorporeal Membrane Oxygenation–supported Acute Respiratory Distress Syndrome?
por: Millar, Jonathan E., et al.
Publicado: (2020)

Emerging pharmacological therapies for ARDS: COVID-19 and beyond
por: Horie, Shahd, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_63gphm33viriv84vvblngmj58u